Hydroxyapatite nanoparticles as vectors for gene delivery.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Gene Therapy

Background:

• Gene therapy holds promise for incurable diseases but lacks efficient delivery vehicles.
• Hydroxyapatite nanoparticles (HANPs) are potential gene vectors due to their favorable characteristics.
• Current HANP fabrication methods yield aggregated and heterogeneous particles unsuitable for gene therapy.

Purpose of the Study:

• To address the need for homogenous, monodispersed HANPs for gene therapy.
• To develop a rapid, efficient, cost-effective, and scalable method for fabricating HANPs.
• To enhance cell transfection efficiency by optimizing HANP properties.

Main Methods:

• Fabrication of hydroxyapatite nanoparticles (HANPs) with controlled size, shape, and surface charge.
• Optimization of reaction conditions to achieve monodispersity and homogeneity.
• Characterization of HANP properties to assess suitability for gene delivery.

Main Results:

• Development of a method for producing uniform HANPs.
• Demonstration that controlled nanoparticle properties enhance gene vector capabilities.
• Identification of tunable physicochemical properties for improved transfection.

Conclusions:

• Homogenous and monodispersed HANPs are essential for advancing gene therapy.
• Precise control over HANP fabrication can overcome limitations of current gene delivery systems.
• Optimized HANPs represent a promising avenue for developing safe and effective gene therapies.